Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Other Accumulated Expenses (2019 - 2025)

Veracyte's Other Accumulated Expenses history spans 11 years, with the latest figure at $19000.0 for Q4 2024.

  • For Q4 2024, Other Accumulated Expenses changed N/A year-over-year to $19000.0; the TTM value through Dec 2024 reached $19000.0, changed N/A, while the annual FY2024 figure was $19000.0, N/A changed from the prior year.
  • Other Accumulated Expenses for Q4 2024 was $19000.0 at Veracyte, down from $127000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.7 million in Q2 2020 and bottomed at $19000.0 in Q4 2024.
  • The 5-year median for Other Accumulated Expenses is $224500.0 (2021), against an average of $721000.0.
  • The largest annual shift saw Other Accumulated Expenses crashed 88.32% in 2021 before it fell 19.48% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $2.1 million in 2020, then tumbled by 88.8% to $231000.0 in 2021, then dropped by 19.48% to $186000.0 in 2022, then crashed by 31.72% to $127000.0 in 2023, then tumbled by 85.04% to $19000.0 in 2024.
  • Per Business Quant, the three most recent readings for VCYT's Other Accumulated Expenses are $19000.0 (Q4 2024), $127000.0 (Q1 2023), and $186000.0 (Q4 2022).